The North America Enteral Nutrition Market is poised for substantial growth from 2020 to 2030, fueled by progress in medical nutrition, an older population, and a rising prevalence of chronic diseases that require specialized nutritional assistance. Enteral nutrition, which provides nutrients directly to the gastrointestinal tract through feeding tubes, is an essential aspect of managing patients who cannot fulfill their nutritional needs through normal oral intake because of conditions like stroke, traumatic injuries, cancer, and gastrointestinal issues. The market is undergoing significant growth as healthcare providers increasingly acknowledge the clinical advantages of early nutritional intervention in enhancing patient outcomes, minimizing hospital stays, and decreasing healthcare expenses. Technological advancements in formulation, delivery systems, and packaging have also aided market growth by improving product safety, administration ease, and patient adherence. Manufacturers are allocating resources to research and development to produce advanced enteral formulas customized to meet the specific nutritional requirements of different patient groups, including those with metabolic disorders, renal failure, or immune deficiencies. The increasing prevalence of obesity and related issues such as type 2 diabetes has escalated the demand for specialized enteral nutrition products that assist in weight management and metabolic regulation.
North America enteral nutrition market is expected to grow by 7.8% annually in the forecast period and reach $5,873.8 million by 2030. Regulatory agencies in North America, especially the U. S. Food and Drug Administration (FDA) and Health Canada, have implemented stringent regulations to ensure the quality and effectiveness of enteral nutrition products, which has consequently enhanced consumer and provider trust in these therapies. Moreover, the growth of home healthcare services and longterm care facilities has opened new avenues for market participants, as more patients are receiving enteral nutrition outside typical hospital environments. The incorporation of digital health technologies, like remote monitoring and telehealth platforms, is also transforming the market by allowing healthcare professionals to monitor patient progress and modify nutritional therapies in realtime. Consequently, both established multinational corporations and emerging local entities are actively broadening their product offerings and distribution channels to seize a larger segment of the expanding market. Strategic partnerships and collaborations among manufacturers, healthcare providers, and research institutions are further promoting innovation, resulting in the creation of nextgeneration enteral nutrition solutions that provide better bioavailability, targeted nutrient delivery, and greater patient acceptance. Overall, the North America Enteral Nutrition Market is on a growth path, supported by advantageous demographic trends, technological progress, and a strong commitment to enhancing patient care, which together position the market for continued growth and innovation through 2030.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Critical Care applications generate significant income due to the intensive nutritional requirements of patients in severe conditions, whereas the Diabetes segment concentrates on specialized formulations for metabolic management. Neurology and Oncology applications serve patients with complex, specific condition needs, which increases the demand for tailored nutritional support. Other Applications encompass additional therapeutic areas, responding to various clinical challenges. This segmentation highlights the market’s adaptability to different patient requirements and changing clinical practices, fostering targeted innovation and revenue growth. Enteral Nutrition for Chronic Illness meets the specialized needs of patients with longterm health conditions, providing tailored nutrients to enhance clinical outcomes and overall quality of life. Conversely, Enteral Nutrition with Standard Formula delivers a more general nutritional solution that is suitable for a wider patient population, guaranteeing consistent, costeffective support in routine care. This categorization illustrates the varied clinical needs and strategic pricing models that propel market growth. The North America enteral nutrition market is structured by product form into Liquid Enteral Nutrition and Powder Enteral Nutrition, with annual revenue ($ mn) statistics provided for 20192030.
Liquid Enteral Nutrition is preferred for its ease of administration, quick absorption, and suitability for patients with compromised digestion, whereas Powder Enteral Nutrition presents benefits in storage, preparation flexibility, and costefficiency. Pediatric formulations are designed for children with specific nutritional requirements, ensuring safe and efficient growth support. The adult segment aims at delivering comprehensive nutrition for individuals with chronic illnesses and recovery after surgery, whereas the geriatric segment tackles agerelated nutritional issues, like decreased appetite and impaired digestion. Each segment showcases specific product formulations and clinical advantages, facilitating revenue growth as healthcare providers enhance nutritional support during various life stages globally both today and consistently. Hospital distribution channels predominantly cater to inpatient environments, guaranteeing prompt access to enteral nutrition products for critical and acute care patients. Retail pharmacies address outpatient requirements by offering nutritional formulations for chronic conditions, while online pharmacies are expanding due to the convenience and digital ordering systems. Every channel is essential in broadening market access, improving patient availability, and promoting overall revenue growth throughout the region.
Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030
Make this report your own
Have queries/questions regarding a report
Take advantage of intelligence tailored to your business objective
Sikandar Kesari
Research Analyst
Aspects covered in this report
• North America Enteral Nutrition Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation
Based on Nutrient, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Protein Based Nutrition
• Standard Protein Diet
• High Protein Supplement
• Protein for Diabetic Patients
• Other Protein-based Nutitions
• Carbohydrates Based Nutrition
• Fat Based Nutrition
• Vitamin Based Nutrition
• Other Nutrition Types
Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Critical Care
• Diabetes
• Neurology
• Oncology
• Other Applications
Don’t pay for what you don’t need. Save 30%
Customise your report by selecting specific countries or regions
Based on Category, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Enteral Nutrition for Chronic Illness
• Enteral Nutrition with Standard Formula
Based on Product Form, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Liquid Enteral Nutrition
• Powder Enteral Nutrition
Based on End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Pediatric
• Adults
• Geriatric
Based on Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Distribution by Hospitals
• Distribution by Retail Pharmacies
• Distribution by Online Pharmacies
The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analyzing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources.
Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to agriculture industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.
Table of Contents
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter’s Fiver Forces Analysis 36
3 Segmentation of North America Market by Nutrient 40
3.1 Market Overview by Nutrient 40
3.2 Protein Based Nutrition 42
3.2.1 Standard Protein Diet 44
3.2.2 High Protein Supplement 45
3.2.3 Protein for Diabetic Patients 46
3.2.4 Other Protein-based Nutitions 47
3.3 Carbohydrates Based Nutrition 48
3.4 Fat Based Nutrition 49
3.5 Vitamin Based Nutrition 50
3.6 Other Nutrition Types 51
4 Segmentation of North America Market by Application 52
4.1 Market Overview by Application 52
4.2 Critical Care 54
4.3 Diabetes 55
4.4 Neurology 56
4.5 Oncology 57
4.6 Other Applications 58
5 Segmentation of North America Market by Category 59
5.1 Market Overview by Category 59
5.2 Enteral Nutrition for Chronic Illness 61
5.3 Enteral Nutrition with Standard Formula 62
6 Segmentation of North America Market by Product Form 63
6.1 Market Overview by Product Form 63
6.2 Liquid Enteral Nutrition 65
6.3 Powder Enteral Nutrition 66
7 Segmentation of North America Market by End User 67
7.1 Market Overview by End User 67
7.2 Pediatric 69
7.3 Adults 70
7.4 Geriatric 71
8 Segmentation of North America Market by Distribution Channel 72
8.1 Market Overview by Distribution Channel 72
8.2 Distribution by Hospitals 74
8.3 Distribution by Retail Pharmacies 75
8.4 Distribution by Online Pharmacies 76
9 North America Market 2019-2030 by Country 77
9.1 Overview of North America Market 77
9.2 U.S. 80
9.3 Canada 83
9.4 Mexico 85
10 Competitive Landscape 87
10.1 Overview of Key Vendors 87
10.2 New Product Launch, Partnership, Investment, and M&A 90
10.3 Company Profiles 91
Abbott Laboratories 91
B. Braun Melsungen AG 93
Baxter International, Inc. 97
Danone S.A. 100
Fresenius Kabi AG 103
Global Health Products, Inc. 107
Hormel Foods Corporation 109
Meiji Holdings Co., Ltd. 111
Nestle S.A. 113
Reckitt Benckiser (Mead Johnson & Company LLC) 118
Victus, Inc. 121
11 Investing in North America Market: Risk Assessment and Management 123
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information